Stockholders' Equity (Deficit)

12 Months Ended

Dec. 31, 2019

Equity:

Stockholders' Equity (Deficit)

Note 6 – Stockholders’ Equity (Deficit)

Warrants

During September 2015, the Company issued five-year warrants to a stockholder for the purchase 25,000 shares of common stock at an exercise price of $.12 per share as additional consideration for a $25,000 loan. These warrants expire in September 2020. As of December 31, 2019, all of these warrants were outstanding.

During June 2016, the Company issued warrants to a stockholder for the purchase of 900,000 shares of common stock at an exercise price of $0.11 per share in consideration for the Company utilizing his facility space from January 2013 to December 2015. These warrants expire in June 2021. As of December 31, 2019, all of these warrants were outstanding.

In July 2016, a warrant for the purchase of 25,000 shares of common stock at an exercise price of $.19 per share was issued to a stockholder as additional consideration for a $25,000 loan. These warrants expire in July 2021. As of December 31, 2019, all of these warrants were outstanding.

In October 2016, another warrant for the purchase of 25,000 shares of common stock was issued to the same stockholder at an exercise price of $.15 per share as additional consideration for extending the maturity of the $25,000 loan for an additional 90 days. These warrants expire in October 2021. As of December 31, 2019, all of these warrants were outstanding.

A summary of warrants issued, exercised and expired during the year ending December 31, 2018 is as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value
Balance at December 31, 2018		975,000	$	0.11		—
Issued		—		—		—
Expired		—		—		—
Converted to Common Stock Options		—		—		—
Balance at December 31, 2019		975,000	$	0.11		—